International Journal of Endocrinology and Metabolism

Published by: Kowsar

Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases

Aidin Baghbani-Oskouei 1 , Maryam Tohidi 1 , * , Samaneh Asgari 1 , Azra Ramezankhani 1 , Fereidoun Azizi 1 , 2 and Farzad Hadaegh 1
Authors Information
1 Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: October 2018, 16 (4 (Suppl)); e84750
  • Published Online: October 16, 2018
  • Article Type: Review Article
  • Received: September 1, 2018
  • Revised: October 2, 2018
  • Accepted: October 7, 2018
  • DOI: 10.5812/ijem.84750

To Cite: Baghbani-Oskouei A, Tohidi M, Asgari S, Ramezankhani A, Azizi F, et al. Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases, Int J Endocrinol Metab. 2018 ; 16(4 (Suppl)):e84750. doi: 10.5812/ijem.84750.

Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8. [PubMed: 23245609]. [PubMed Central: PMC4156511].
  • 2. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. [PubMed: 24239923].
  • 3. Peters SA, Singhateh Y, Mackay D, Huxley RR, Woodward M. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis. Atherosclerosis. 2016;248:123-31. doi: 10.1016/j.atherosclerosis.2016.03.016. [PubMed: 27016614].
  • 4. Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, et al. Lipid profile components and risk of ischemic stroke: The Northern Manhattan study (NOMAS). Arch Neurol. 2009;66(11):1400-6. doi: 10.1001/archneurol.2009.210. [PubMed: 19901173]. [PubMed Central: PMC2830863].
  • 5. Nomikos T, Panagiotakos D, Georgousopoulou E, Metaxa V, Chrysohoou C, Skoumas I, et al. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: The ATTICA study. Lipids Health Dis. 2015;14:108. doi: 10.1186/s12944-015-0101-7. [PubMed: 26370413]. [PubMed Central: PMC4570524].
  • 6. von Muhlen D, Langer RD, Barrett-Connor E. Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (the rancho bernardo study). Am J Cardiol. 2003;91(11):1311-5. [PubMed: 12767422].
  • 7. Liu J, Zeng FF, Liu ZM, Zhang CX, Ling WH, Chen YM. Effects of blood triglycerides on cardiovascular and all-cause mortality: A systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis. 2013;12:159. doi: 10.1186/1476-511X-12-159. [PubMed: 24164719]. [PubMed Central: PMC4231478].
  • 8. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-74. doi: 10.1038/nature01323. [PubMed: 12490960].
  • 9. Helkin A, Stein JJ, Lin S, Siddiqui S, Maier KG, Gahtan V. Dyslipidemia part 1 review of lipid metabolism and vascular cell physiology. Vasc Endovascular Surg. 2016;50(2):107-18. doi: 10.1177/1538574416628654. [PubMed: 26983667].
  • 10. Frank AT, Zhao B, Jose PO, Azar KM, Fortmann SP, Palaniappan LP. Racial/ethnic differences in dyslipidemia patterns. Circulation. 2014;129(5):570-9. doi: 10.1161/CIRCULATIONAHA.113.005757. [PubMed: 24192801]. [PubMed Central: PMC4212818].
  • 11. Azizi F, Rahmani M, Madjid M, Allahverdian S, Ghanbili J, Ghanbarian A, et al. Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study. Eur J Epidemiol. 2001;17(3):281-8. [PubMed: 11680549].
  • 12. Hatami M, Tohidi M, Mohebi R, Khalili D, Azizi F, Hadaegh F. Adolescent lipoprotein classifications according to national health and nutrition examination survey (NHANES) vs. national cholesterol education program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population. Lipids Health Dis. 2012;11:107. doi: 10.1186/1476-511X-11-107. [PubMed: 22937812]. [PubMed Central: PMC3477115].
  • 13. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, et al. Serum lipid levels in an Iranian adults population: Tehran lipid and glucose study. Eur J Epidemiol. 2003;18(4):311-9. [PubMed: 12803371].
  • 14. Hosseini-Esfahani F, Mousavi Nasl Khameneh A, Mirmiran P, Ghanbarian A, Azizi F. Trends in risk factors for cardiovascular disease among Iranian adolescents: The Tehran lipid and glucose study, 1999-2008. J Epidemiol. 2011;21(5):319-28. doi: 10.2188/jea.JE20100162. [PubMed: 21804294]. [PubMed Central: PMC3899430].
  • 15. Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, et al. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 2014;13:20. doi: 10.1186/1476-511X-13-20. [PubMed: 24456699]. [PubMed Central: PMC3912503].
  • 16. Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, et al. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: A Middle Eastern cohort study. PLoS One. 2014;9(12). e112639. doi: 10.1371/journal.pone.0112639. [PubMed: 25461381]. [PubMed Central: PMC4251920].
  • 17. Eslami A, Lotfaliany M, Akbarpour S, Azizi F, Hadaegh F. Trend of cardiovascular risk factors in the older Iranian population: 2002-2014. Geriatr Gerontol Int. 2018;18(1):130-7. doi: 10.1111/ggi.13154. [PubMed: 28857406].
  • 18. Hadaegh F, Harati H, Zabetian A, Azizi F. Seasonal variability of serum lipids in adults: Tehran lipid and glucose study. Med J Malaysia. 2006;61(3):332-8. [PubMed: 17240585].
  • 19. Tohidi M, Hatami M, Hadaegh F, Azizi F. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women. J Hum Hypertens. 2012;26(9):525-32. doi: 10.1038/jhh.2011.70. [PubMed: 21776016].
  • 20. Bozorgmanesh M, Ghoreishian H, Mohebi R, Azizi F, Hadaegh F. Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population. Eur J Prev Cardiol. 2014;21(8):956-63. doi: 10.1177/2047487313481757. [PubMed: 23478742].
  • 21. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F. Lipid ratios and appropriate cut off values for prediction of diabetes: A cohort of Iranian men and women. Lipids Health Dis. 2010;9:85. doi: 10.1186/1476-511X-9-85. [PubMed: 20712907]. [PubMed Central: PMC2933665].
  • 22. Tohidi M, Mohebi R, Cheraghi L, Hajsheikholeslami F, Aref S, Nouri S, et al. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran lipid and glucose study. Clin Biochem. 2013;46(9):716-21. doi: 10.1016/j.clinbiochem.2013.03.012. [PubMed: 23531403].
  • 23. Ghasemzadeh Z, Abdi H, Asgari S, Tohidi M, Khalili D, Valizadeh M, et al. Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population. Nutr Metab (Lond). 2016;13:43. doi: 10.1186/s12986-016-0102-1. [PubMed: 27346994]. [PubMed Central: PMC4919865].
  • 24. Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, et al. Predictors of early adulthood hypertension during adolescence: A population-based cohort study. BMC Public Health. 2017;17(1):915. doi: 10.1186/s12889-017-4922-3. [PubMed: 29183297]. [PubMed Central: PMC5706303].
  • 25. Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One. 2013;8(9). e76304. doi: 10.1371/journal.pone.0076304. [PubMed: 24086723]. [PubMed Central: PMC3785433].
  • 26. Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study. PLoS One. 2014;9(7). e102563. doi: 10.1371/journal.pone.0102563. [PubMed: 25029368]. [PubMed Central: PMC4100911].
  • 27. Hadaegh F, Derakhshan A, Zafari N, Khalili D, Mirbolouk M, Saadat N, et al. Pre-diabetes tsunami: Incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med. 2017;34(1):69-78. doi: 10.1111/dme.13034. [PubMed: 26606421].
  • 28. Derakhshan A, Tohidi M, Hajebrahimi MA, Saadat N, Azizi F, Hadaegh F. Sex-specific incidence rates and risk factors of insulin resistance and beta-cell dysfunction: A decade follow-up in a Middle Eastern population. Diabet Med. 2017;34(2):245-52. doi: 10.1111/dme.13117. [PubMed: 26996519].
  • 29. Hashemi Nazari SS, Shakiba M, Khalili D, Hadaegh F, Tohidi M, Azizi F. High-density lipoprotein cholesterol, a protective or a risk factor for developing coronary heart disease? Tehran lipid and glucose study. J Clin Lipidol. 2015;9(4):553-8. doi: 10.1016/j.jacl.2015.04.001. [PubMed: 26228673].
  • 30. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009;19(6):401-8. doi: 10.1016/j.numecd.2008.09.003. [PubMed: 19091534].
  • 31. Nejat A, Mirbolouk M, Mohebi R, Hasheminia M, Tohidi M, Saadat N, et al. Changes in lipid measures and incident coronary heart disease: Tehran lipid and glucose study. Clin Biochem. 2014;47(13-14):1239-44. doi: 10.1016/j.clinbiochem.2014.03.004. [PubMed: 24657509].
  • 32. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study. Eur J Cardiovasc Prev Rehabil. 2006;13(4):571-7. doi: 10.1097/ [PubMed: 16874147].
  • 33. Tohidi M, Hatami M, Hadaegh F, Safarkhani M, Harati H, Azizi F. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: Results of the 8.6 years follow-up of a population based cohort study. Lipids Health Dis. 2010;9:6. doi: 10.1186/1476-511X-9-6. [PubMed: 20096127]. [PubMed Central: PMC2835707].
  • 34. Sardarinia M, Akbarpour S, Lotfaliany M, Bagherzadeh-Khiabani F, Bozorgmanesh M, Sheikholeslami F, et al. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a Middle Eastern population over a decade follow-up: Tehran lipid and glucose study. PLoS One. 2016;11(12). e0167623. doi: 10.1371/journal.pone.0167623. [PubMed: 27930696]. [PubMed Central: PMC5145170].
  • 35. Torabi P, Shekholeslam R, Safavi SM. Study of vegetable oil consumption in 15 pilot universities of Iran. 12th Nutritional Congress. Tabriz, Iran. 2004. Persian.
  • 36. Mohammadifard N, Toghianifar N, Sajjadi F, Alikhasi H, Kelishadi R, Maghroun M, et al. Improvement of dietary oil consumption following a community trial in a developing country: The role of translational research in health promotion. ARYA Atheroscler. 2013;9(1):29-37. [PubMed: 23696757]. [PubMed Central: PMC3653266].
  • 37. White J, Swerdlow DI, Preiss D, Fairhurst-Hunter Z, Keating BJ, Asselbergs FW, et al. Association of lipid fractions with risks for coronary artery disease and diabetes. JAMA Cardiol. 2016;1(6):692-9. doi: 10.1001/jamacardio.2016.1884. [PubMed: 27487401]. [PubMed Central: PMC5642865].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments